|
1
|
The primed ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding.
|
J Virol
|
2009
|
2.15
|
|
2
|
FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection.
|
Sci Transl Med
|
2013
|
1.62
|
|
3
|
Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change.
|
J Virol
|
2011
|
1.46
|
|
4
|
Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection.
|
PLoS One
|
2013
|
1.29
|
|
5
|
Cell adhesion-dependent membrane trafficking of a binding partner for the ebolavirus glycoprotein is a determinant of viral entry.
|
Proc Natl Acad Sci U S A
|
2010
|
1.14
|
|
6
|
A new player in the puzzle of filovirus entry.
|
Nat Rev Microbiol
|
2012
|
1.08
|
|
7
|
Cell adhesion promotes Ebola virus envelope glycoprotein-mediated binding and infection.
|
J Virol
|
2008
|
1.05
|
|
8
|
Analysis of hemF gene function and expression in Rhodobacter sphaeroides 2.4.1.
|
J Bacteriol
|
2006
|
0.80
|